Literature DB >> 20981798

Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults.

Michiko Okamoto1, Kanetsu Sugawara, Emi Takashita, Yasushi Muraki, Seiji Hongo, Hidekazu Nishimura, Yoko Matsuzaki.   

Abstract

The purpose of this study was to evaluate the frequency of human metapneumovirus (hMPV) infection in adults and to determine the association between the levels of serum antibody titers and the susceptibility to reinfection. Serum samples collected at the periodic occupational medical checkup for employees of a hospital were subjected to an ELISA test. Of the 289 subjects, 288 (99.7%) had hMPV antibody titers that were more than 1:100 in May 2006. The percentage of subjects with a titer of ≥ 3,200 was significantly higher in adults aged 40-65 years old (30.2-31.5%) compared to young adults 20-39 years old (13.6%) (P < 0.05). To investigate the longitudinal course of the hMPV antibody titer, a total of 649 serum samples collected from 59 subjects who had participated in all biannual medical checkups between 2001 and 2006 were tested. We found that ten serum pairs showed a greater than fourfold increase in hMPV antibody titers. Additionally, the 5-year reinfection rate was estimated at 16.9% (10 of 59 subjects). The baseline titer before the fourfold increase ranged from 1:100 to 1:3,200, and the titer returned to baseline levels 2 or 3 years after the fourfold increase. The antibody titer of the person with the baseline titer of 1:100 showed a greater than fourfold increase twice within a year. Sixty to 80% of adults had an ELISA titer of 1:800 to 1:1,600, suggesting that such an antibody titer is not enough to protect from hMPV infection and that reinfection could occur among adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981798     DOI: 10.1002/jmv.21920

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 2.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 3.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

4.  Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.

Authors:  Reagan G Cox; John J Erickson; Andrew K Hastings; Jennifer C Becker; Monika Johnson; Ryan E Craven; Sharon J Tollefson; Kelli L Boyd; John V Williams
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Authors:  Cyril Le Nouën; Philippa Hillyer; Linda G Brock; Christine C Winter; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.

Authors:  John J Erickson; Meredith C Rogers; Andrew K Hastings; Sharon J Tollefson; John V Williams
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

7.  Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.

Authors:  Andrew K Hastings; John J Erickson; Jennifer E Schuster; Kelli L Boyd; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

8.  Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua.

Authors:  Kathryn Hacker; Guillermina Kuan; Nivea Vydiswaran; Gerardo Chowell-Puente; Mayuri Patel; Nery Sanchez; Roger Lopez; Sergio Ojeda; Brenda Lopez; Jarrod Mousa; Hannah E Maier; Angel Balmaseda; Aubree Gordon
Journal:  Influenza Other Respir Viruses       Date:  2022-08-14       Impact factor: 5.606

9.  Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells.

Authors:  Pablo F Céspedes; Pablo A Gonzalez; Alexis M Kalergis
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

10.  Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

Authors:  Maximillian S Habibi; Agnieszka Jozwik; Spyridon Makris; Jake Dunning; Allan Paras; John P DeVincenzo; Cornelis A M de Haan; Jens Wrammert; Peter J M Openshaw; Christopher Chiu
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.